Prostate Cancer

Stage refers to the extent of the cancer. Early prostate cancer, stages I and II, is localized. It has not spread outside the prostate gland. Stage III prostate cancer, often called locally advanced disease, extends outside the gland and may be in the... Full Answer

The seriousness of prostate cancer depends on the stage at which it is diagnosed. Five-year survival rates can range from 100 percent for early stages that have yet to spread beyond the prostate to 30 percent for later stages in which the cancer has... Full Answer

The risk of prostate cancer is higher in African American men compared to both white and Hispanic men.  Prostate cancer is at times diagnosed at an earlier age in African American men compared to white and Hispanic men, as well. Full Answer

Physicians don't know when prostate cancer starts. It's assumed that the cancer starts in the 20s or 30s and grows, says William Oh, MD, an oncologist at The Mount Sinai Medical Center. In this video, he discusses when prostate cancer may begin. Full Answer

The cause of prostate cancer is unknown. The disease begins as a small bump of abnormal cells located within the prostate. These cancerous cells do not die like normal cells, and they divide at a much higher rate as well. Therefore over time, sometimes... Full Answer

In the past, most prostate cancer patients presented with metastatic prostate cancer. In this video, Simon Hall, MD, a urologist at The Mount Sinai Medical Center and director of the Deane Prostate Health and Research Center, explains what... Full Answer

Researchers are developing new tests for prostate cancer, but they're expensive. In this video, Simon Hall, MD, a urologist at The Mount Sinai Medical Center, discusses the PSA. Full Answer

Prostate cancer cells mix with regular cells, making it harder to detect. In this video, Simon Hall, MD,  a urologist at The Mount Sinai Medical Center and director of the Deane Prostate Health and Research Center, explains postate imaging. Full Answer

Better screening and treatment guidelines are in the future of prostate cancer treatment, says Simon Hall, MD,  a urologist at The Mount Sinai Medical Center and director of the Deane Prostate Health and Research Center. Full Answer

Doctors have learned a lot about prostate cancer, says David Samadi, MD, chief of robotics and minimal invasive surgery at The Mount Sinai School of Medicine. Watch as he discusses the current understanding of prostate cancer. Full Answer